| Reference |
|---|
Cheng Y, Yu Y, Zhuang Q, Wang L, Zhan B, Du S, et al. Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte/macrophage polarization. iScience. 2022;25:103979 pubmed publisher |
Holling T, Bhavani G, von Elsner L, Shah H, Kausthubham N, Bhattacharyya S, et al. A homozygous hypomorphic BNIP1 variant causes an increase in autophagosomes and reduced autophagic flux and results in a spondylo-epiphyseal dysplasia. Hum Mutat. 2022;43:625-642 pubmed publisher |
Miek L, Jordan P, G xfc nther K, Pace S, Beyer T, Kowalak D, et al. Staphylococcus aureus controls eicosanoid and specialized pro-resolving mediator production via lipoteichoic acid. Immunology. 2022;166:47-67 pubmed publisher |
Soma T, Iwasaki R, Sato Y, Kobayashi T, Ito E, Matsumoto T, et al. Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics. Sci Rep. 2022;12:19 pubmed publisher |
Ma J, Lu J, Zhou Z, Lu N, He J, Zhu L, et al. TRPV6 is a potential regulator of bone resorption in bone loss induced by estrogen deficiency. iScience. 2021;24:103261 pubmed publisher |
Sun J, Chen W, Li S, Yang S, Zhang Y, Hu X, et al. Nox4 Promotes RANKL-Induced Autophagy and Osteoclastogenesis via Activating ROS/PERK/eIF-2α/ATF4 Pathway. Front Pharmacol. 2021;12:751845 pubmed publisher |
Kim H, Song M, Gho Y, Kim H, Choi B. Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 2. J Extracell Vesicles. 2021;10:e12157 pubmed publisher |
He Y, Cheng D, Lian C, Liu Y, Luo W, Wang Y, et al. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone. Cell Death Dis. 2021;12:868 pubmed publisher |
Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021;12:5196 pubmed publisher |
Yamada H, Saegusa J, Sendo S, Ueda Y, Okano T, Shinohara M, et al. Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis. Sci Rep. 2021;11:17312 pubmed publisher |
Ambrosi T, Marecic O, McArdle A, Sinha R, Gulati G, Tong X, et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. 2021;597:256-262 pubmed publisher |
Di Lorenzo G, Westermann L, Yorgan T, St xfc rznickel J, Ludwig N, Ammer L, et al. Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III. Genet Med. 2021;23:2369-2377 pubmed publisher |
Jin F, Li J, Zhang Y, Liu X, Cai M, Liu M, et al. A functional motif of long noncoding RNA Nron against osteoporosis. Nat Commun. 2021;12:3319 pubmed publisher |
Polavaram N, Dutta S, Islam R, Bag A, Roy S, Poitz D, et al. Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases. Bone Res. 2021;9:24 pubmed publisher |
Liu J, Chen C, Liu Z, Luo Z, Rao S, Jin L, et al. Extracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and Strength. Adv Sci (Weinh). 2021;8:2004831 pubmed publisher |
Deng C, Zhang Q, He P, Zhou B, He K, Sun X, et al. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nat Commun. 2021;12:2174 pubmed publisher |
Lee S, Park K, Lee G, Kim S, Song W, Kwon S, et al. Hypoxia-inducible factor-2α mediates senescence-associated intrinsic mechanisms of age-related bone loss. Exp Mol Med. 2021;53:591-604 pubmed publisher |
Westermann L, Baranowsky A, Di Lorenzo G, Danyukova T, Soul J, Schwartz J, et al. Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice. Sci Rep. 2021;11:3556 pubmed publisher |
Kanji S, Sarkar R, Pramanik A, Kshirsagar S, Greene C, Das H. Dental pulp-derived stem cells inhibit osteoclast differentiation by secreting osteoprotegerin and deactivating AKT signalling in myeloid cells. J Cell Mol Med. 2021;25:2390-2403 pubmed publisher |
Yu L, Sui B, Fan W, Lei L, Zhou L, Yang L, et al. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p. J Extracell Vesicles. 2021;10:e12056 pubmed publisher |
Yu W, Chen C, Kou X, Sui B, Yu T, Liu D, et al. Mechanical force-driven TNFα endocytosis governs stem cell homeostasis. Bone Res. 2021;8:44 pubmed publisher |
Chen Z, Cho E, Ding M, Seong J, Che X, Lee S, et al. N-[2-(4-benzoyl-1-piperazinyl)phenyl]-2-(4-chlorophenoxy) acetamide is a novel inhibitor of resorptive bone loss in mice. J Cell Mol Med. 2021;25:1425-1438 pubmed publisher |
Huang C, Zheng Y, Bai J, Shi C, Shi X, Shan H, et al. Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice. J Orthop Translat. 2021;27:9-16 pubmed publisher |
Lee H, Cho K, Kim M, Lee M, Kim H, Choi C, et al. Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca2+ /calmodulin-mediated osteoclast differentiation. J Cell Mol Med. 2021;25:473-483 pubmed publisher |
Hendrickx G, Fischer V, Liedert A, von Kroge S, Haffner Luntzer M, Brylka L, et al. Piezo1 Inactivation in Chondrocytes Impairs Trabecular Bone Formation. J Bone Miner Res. 2021;36:369-384 pubmed publisher |
Ma J, Zhu L, Zhou Z, Song T, Yang L, Yan X, et al. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway. Cell Prolif. 2021;54:e12955 pubmed publisher |
Korn M, Schmitt H, Angermüller S, Chambers D, Seeling M, Lux U, et al. Siglec-15 on Osteoclasts Is Crucial for Bone Erosion in Serum-Transfer Arthritis. J Immunol. 2020;205:2595-2605 pubmed publisher |
Andreev D, Liu M, Weidner D, Kachler K, Faas M, Grüneboom A, et al. Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. J Clin Invest. 2020;130:4811-4830 pubmed publisher |
Jeong E, Kim J, Go M, Lee S. Early estrogen-induced gene 1 facilitates osteoclast formation through the inhibition of interferon regulatory factor 8 expression. FASEB J. 2020;34:12894-12906 pubmed publisher |
Jin C, Jia L, Tang Z, Zheng Y. Long non-coding RNA MIR22HG promotes osteogenic differentiation of bone marrow mesenchymal stem cells via PTEN/ AKT pathway. Cell Death Dis. 2020;11:601 pubmed publisher |
Suresh S, Lee J, Noguchi C. Erythropoietin signaling in osteoblasts is required for normal bone formation and for bone loss during erythropoietin-stimulated erythropoiesis. FASEB J. 2020;34:11685-11697 pubmed publisher |
Pang C, Wen L, Qin H, Zhu B, Lu X, Luo S. Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA. J Cell Mol Med. 2020;24:8452-8465 pubmed publisher |
Li B, Lee W, Song C, Ye L, Abel E, Long F. Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation. FASEB J. 2020;34:11058-11067 pubmed publisher |
Jiao Y, Chen C, Hu X, Feng X, Shi Z, Cao J, et al. Niclosamide and its derivative DK-520 inhibit RANKL-induced osteoclastogenesis. FEBS Open Bio. 2020;10:1685-1697 pubmed publisher |
Kittaka M, Yoshimoto T, Schlosser C, Kajiya M, Kurihara H, REICHENBERGER E, et al. Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice. JBMR Plus. 2020;4:e10352 pubmed publisher |
Rocha F, Delitto A, de Souza J, Gonz xe1 lez Maldonado L, Wallet S, Rossa Junior C. Relevance of Caspase-1 and Nlrp3 Inflammasome on Inflammatory Bone Resorption in A Murine Model of Periodontitis. Sci Rep. 2020;10:7823 pubmed publisher |
Yang M, Li C, Xiao Y, Guo Q, Huang Y, Su T, et al. Ophiopogonin D promotes bone regeneration by stimulating CD31hi EMCNhi vessel formation. Cell Prolif. 2020;53:e12784 pubmed publisher |
Song C, Cao J, Lei Y, Chi H, Kong P, Chen G, et al. Nuciferine prevents bone loss by disrupting multinucleated osteoclast formation and promoting type H vessel formation. FASEB J. 2020;34:4798-4811 pubmed publisher |
Wang L, You X, Lotinun S, Zhang L, Wu N, Zou W. Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk. Nat Commun. 2020;11:282 pubmed publisher |
Zheng W, Ding B, Li X, Liu D, Yokota H, Zhang P. Knee loading repairs osteoporotic osteoarthritis by relieving abnormal remodeling of subchondral bone via Wnt/β-catenin signaling. FASEB J. 2020;34:3399-3412 pubmed publisher |
Wang J, Guan H, Liu H, Lei Z, Kang H, Guo Q, et al. Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss. J Cell Mol Med. 2020;24:2294-2307 pubmed publisher |
Zhao X, Cui P, Hu G, Wang C, Jiang L, Zhao J, et al. PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation. J Mol Cell Biol. 2020;12:55-70 pubmed publisher |
Zhuang X, Hu G. In vitro Osteoclastogenesis Assays Using Primary Mouse Bone Marrow Cells. Bio Protoc. 2018;8:e2875 pubmed publisher |
Wagner A, Alan B, Yilmaz D, Ahmad M, Liu P, Tangudu N, et al. Despite Genetic Iron Overload, Hfe-Hemochromatosis Mice Do Not Show Bone Loss. JBMR Plus. 2019;3:e10206 pubmed publisher |
Suresh S, de Castro L, Dey S, Robey P, Noguchi C. Erythropoietin modulates bone marrow stromal cell differentiation. Bone Res. 2019;7:21 pubmed publisher |
Omi M, Kaartinen V, Mishina Y. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway. J Biol Chem. 2019;294:17818-17836 pubmed publisher |
Yamamoto M, Abe C, Wakinaga S, Sakane K, Yumiketa Y, Taguchi Y, et al. TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion. Commun Biol. 2019;2:292 pubmed publisher |
Kang J, Choi Y, Seo B, Jo U, Park S, Kim Y, et al. A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment. Sci Rep. 2019;9:8726 pubmed publisher |
Dong L, Wu J, Chen K, Xie J, Wang Y, Li D, et al. Mannan-Binding Lectin Attenuates Inflammatory Arthritis Through the Suppression of Osteoclastogenesis. Front Immunol. 2019;10:1239 pubmed publisher |
Yang M, Guo Q, Peng H, Xiao Y, Xiao Y, Huang Y, et al. Krüppel-like factor 3 inhibition by mutated lncRNA Reg1cp results in human high bone mass syndrome. J Exp Med. 2019;: pubmed publisher |
Lee S, Park K, Yu H, Kook E, Song W, Lee G, et al. Controlling hypoxia-inducible factor-2α is critical for maintaining bone homeostasis in mice. Bone Res. 2019;7:14 pubmed publisher |
Zhou F, Mei J, Yuan K, Han X, Qiao H, Tang T. Isorhamnetin attenuates osteoarthritis by inhibiting osteoclastogenesis and protecting chondrocytes through modulating reactive oxygen species homeostasis. J Cell Mol Med. 2019;23:4395-4407 pubmed publisher |
Liu S, Zhou H, Liu H, Ji H, Fei W, Luo E. Fluorine-contained hydroxyapatite suppresses bone resorption through inhibiting osteoclasts differentiation and function in vitro and in vivo. Cell Prolif. 2019;52:e12613 pubmed publisher |
Doonan J, Tarafdar A, Pineda M, Lumb F, Crowe J, Khan A, et al. The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis. Nat Commun. 2019;10:1554 pubmed publisher |
Battaglino R, Jha P, Sultana F, Liu W, Morse L. FKBP12: A partner of Snx10 required for vesicular trafficking in osteoclasts. J Cell Biochem. 2019;120:13321-13329 pubmed publisher |
Nakano S, Inoue K, Xu C, Deng Z, Syrovatkina V, Vitone G, et al. G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function. Sci Rep. 2019;9:4236 pubmed publisher |
Ochiai N, Nakachi Y, Yokoo T, Ichihara T, Eriksson T, Yonemoto Y, et al. Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment. Commun Biol. 2019;2:86 pubmed publisher |
Jiang M, Yan Y, Yang K, Liu Z, Qi J, Zhou H, et al. Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis. J Cell Mol Med. 2019;23:1224-1234 pubmed publisher |
Faict S, Muller J, De Veirman K, De Bruyne E, Maes K, Vrancken L, et al. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J. 2018;8:105 pubmed publisher |
Neugebauer J, Heilig J, Hosseinibarkooie S, Ross B, Mendoza Ferreira N, Nolte F, et al. Plastin 3 influences bone homeostasis through regulation of osteoclast activity. Hum Mol Genet. 2018;27:4249-4262 pubmed publisher |
Omar I, Guterman Ram G, Rahat D, Tabach Y, Berger M, Levaot N. Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitors. Sci Rep. 2018;8:13005 pubmed publisher |
Tzeng H, Huang P, Tsai C, Tsay G, Lee Y, Huang T, et al. Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis. Sci Rep. 2018;8:11190 pubmed publisher |
Lv Z, Liang S, Chen K, Zhang J, Cheng P, Guo J, et al. FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-κB Activation and CXCL10 Expression. Biomed Res Int. 2018;2018:3936257 pubmed publisher |
Li B, Yu F, Wu F, Wang K, Lou F, Zhang D, et al. Visual Osteoclast Fusion via A Fluorescence Method. Sci Rep. 2018;8:10184 pubmed publisher |
Stegen S, Stockmans I, Moermans K, Thienpont B, Maxwell P, Carmeliet P, et al. Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin. Nat Commun. 2018;9:2557 pubmed publisher |
Matsumoto N, Sekiya M, Tohyama K, Ishiyama Matsuura E, Sun Wada G, Wada Y, et al. Essential Role of the a3 Isoform of V-ATPase in Secretory Lysosome Trafficking via Rab7 Recruitment. Sci Rep. 2018;8:6701 pubmed publisher |
Wu H, Hu B, Zhou X, Zhou C, Meng J, Yang Y, et al. Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway. Cell Death Dis. 2018;9:498 pubmed publisher |
Baek J, Cheon Y, Kwak S, Jun H, Yoon K, Lee M, et al. Claudin 11 regulates bone homeostasis via bidirectional EphB4-EphrinB2 signaling. Exp Mol Med. 2018;50:50 pubmed publisher |
Fu Y, Lu C, Chu K, Yeh C, Chiang T, Ko T, et al. Xenograft of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly Differentiating into Osteocytes and Reducing Osteoclast Activity Reverses Osteoporosis in Ovariectomized Rats. Cell Transplant. 2018;27:194-208 pubmed publisher |
Zach F, Polzer F, Mueller A, Gessner A. p62/sequestosome 1 deficiency accelerates osteoclastogenesis in vitro and leads to Paget's disease-like bone phenotypes in mice. J Biol Chem. 2018;293:9530-9541 pubmed publisher |
Elias S, Morgan M, Bikoff E, Robertson E. Long-lived unipotent Blimp1-positive luminal stem cells drive mammary gland organogenesis throughout adult life. Nat Commun. 2017;8:1714 pubmed publisher |
Kim H, Nam S, Mun S, Lee S, Kim H, Park Y, et al. DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation. Nat Commun. 2017;8:1519 pubmed publisher |
Park M, Kim H, Lee M, Park B, Lee H, Cho E, et al. FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2. Sci Rep. 2017;7:15575 pubmed publisher |
Zhu X, Zhao Y, Jiang Y, Qin T, Chen J, Chu X, et al. Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1. Oncotarget. 2017;8:53366-53374 pubmed publisher |
Kim W, Kim H, Jeong E, Kim H, Lee Z, Kim I, et al. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway. Sci Rep. 2017;7:10626 pubmed publisher |
Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, et al. Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017;7:9473 pubmed publisher |
Watanabe K, Tominari T, Hirata M, Matsumoto C, Hirata J, Murphy G, et al. Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption. FEBS Open Bio. 2017;7:1178-1185 pubmed publisher |
Takito J, Otsuka H, Inoue S, Kawashima T, Nakamura M. Symmetrical retrograde actin flow in the actin fusion structure is involved in osteoclast fusion. Biol Open. 2017;6:1104-1114 pubmed publisher |
Lu L, Rao L, Jia H, Chen J, Lu X, Yang G, et al. Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling. J Cell Mol Med. 2017;21:1361-1372 pubmed publisher |
Herrtwich L, Nanda I, Evangelou K, Nikolova T, Horn V, Sagar -, et al. DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas. Cell. 2016;167:1264-1280.e18 pubmed publisher |
Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, et al. MicroRNA-182 targets SMAD7 to potentiate TGF?-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 2016;7:13884 pubmed publisher |
Kurinami H, Shimamura M, Nakagami H, Shimizu H, Koriyama H, Kawano T, et al. A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke. Sci Rep. 2016;6:38062 pubmed publisher |
Kang I, Kim C. NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1. Sci Rep. 2016;6:38014 pubmed publisher |
Izawa T, Arakaki R, Mori H, Tsunematsu T, Kudo Y, Tanaka E, et al. The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis. J Immunol. 2016;197:4639-4650 pubmed |
Kang H, Yan Y, Jia P, Yang K, Guo C, Chen H, et al. Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1. Cell Death Dis. 2016;7:e2435 pubmed publisher |
Schem C, Tower R, Kneissl P, Rambow A, Campbell G, Desel C, et al. Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases. J Bone Miner Res. 2017;32:536-548 pubmed publisher |
Yang C, Ding P, Wang Q, Zhang L, Zhang X, Zhao J, et al. Inhibition of Complement Retards Ankylosing Spondylitis Progression. Sci Rep. 2016;6:34643 pubmed publisher |
Hirozane T, Tohmonda T, Yoda M, Shimoda M, Kanai Y, Matsumoto M, et al. Conditional abrogation of Atm in osteoclasts extends osteoclast lifespan and results in reduced bone mass. Sci Rep. 2016;6:34426 pubmed publisher |
Sousa D, Concei xe7 xe3 o F, Silva D, Leit xe3 o L, Neto E, Alves C, et al. Ablation of Y1 receptor impairs osteoclast bone-resorbing activity. Sci Rep. 2016;6:33470 pubmed publisher |
Prokopec K, Georgoudaki A, Sohn S, Wermeling F, Grönlund H, Lindh E, et al. Cutting Edge: Marginal Zone Macrophages Regulate Antigen Transport by B Cells to the Follicle in the Spleen via CD21. J Immunol. 2016;197:2063-8 pubmed publisher |
Chen Z, Andreev D, Oeser K, Krljanac B, Hueber A, Kleyer A, et al. Th2 and eosinophil responses suppress inflammatory arthritis. Nat Commun. 2016;7:11596 pubmed publisher |
Lee D, Heo D, Kim H, Ko W, Lee S, Heo M, et al. Inhibition of Osteoclast Differentiation and Bone Resorption by Bisphosphonate-conjugated Gold Nanoparticles. Sci Rep. 2016;6:27336 pubmed publisher |
Park S, Huh J, Shin J, Park D, Ko R, Jin G, et al. Sirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation. Sci Rep. 2016;6:26186 pubmed publisher |
Shi C, Iura A, Terajima M, Liu F, Lyons K, Pan H, et al. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors. Sci Rep. 2016;6:24256 pubmed publisher |
Yim H, Park C, Lee Y, Arimoto K, Jeon R, Baek S, et al. Elevated Response to Type I IFN Enhances RANKL-Mediated Osteoclastogenesis in Usp18-Knockout Mice. J Immunol. 2016;196:3887-95 pubmed publisher |
Su N, Li X, Tang Y, Yang J, Wen X, Guo J, et al. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption. J Bone Miner Res. 2016;31:1676-87 pubmed publisher |
Li D, Liu J, Guo B, Liang C, Dang L, Lu C, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7:10872 pubmed publisher |
Robaszkiewicz A, Qu C, Wiśnik E, Ploszaj T, Mirsaidi A, Kunze F, et al. ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1β. Sci Rep. 2016;6:21131 pubmed publisher |
Kim Y, Yi H, Jung H, Rim Y, Park N, Kim J, et al. A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis. Sci Rep. 2016;6:20150 pubmed publisher |
Watari K, Shibata T, Nabeshima H, Shinoda A, Fukunaga Y, Kawahara A, et al. Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient mice. Sci Rep. 2016;6:19470 pubmed publisher |
Alsulaiman M, Bais M, Trackman P. Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo. J Cell Commun Signal. 2016;10:17-31 pubmed publisher |
Oh E, Lee H, Kim H, Park Y, Seo J, Park J, et al. Serum amyloid A inhibits RANKL-induced osteoclast formation. Exp Mol Med. 2015;47:e194 pubmed publisher |
Garimella M, Kour S, Piprode V, Mittal M, Kumar A, Rani L, et al. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis. J Immunol. 2015;195:5136-48 pubmed publisher |
Yanagihara T, Sanematsu F, Sato T, Uruno T, Duan X, Tomino T, et al. Intronic regulation of Aire expression by Jmjd6 for self-tolerance induction in the thymus. Nat Commun. 2015;6:8820 pubmed publisher |
Jeschke A, Catala Lehnen P, Sieber S, Bickert T, Schweizer M, Koehne T, et al. Sharpin Controls Osteogenic Differentiation of Mesenchymal Bone Marrow Cells. J Immunol. 2015;195:3675-84 pubmed publisher |
Neri T, Muggeo S, Paulis M, Caldana M, Crisafulli L, Strina D, et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Reports. 2015;5:558-68 pubmed publisher |
Zhang Y, Guan H, Li J, Fang Z, Chen W, Li F. Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss. Sci Rep. 2015;5:13575 pubmed publisher |
Drobek A, Kralova J, Skopcova T, Kucova M, Novák P, Angelisová P, et al. PSTPIP2, a Protein Associated with Autoinflammatory Disease, Interacts with Inhibitory Enzymes SHIP1 and Csk. J Immunol. 2015;195:3416-26 pubmed publisher |
Tohmonda T, Yoda M, Iwawaki T, Matsumoto M, Nakamura M, Mikoshiba K, et al. IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. J Clin Invest. 2015;125:3269-79 pubmed publisher |
Pontejo S, Alejo A, Alcami A. Comparative Biochemical and Functional Analysis of Viral and Human Secreted Tumor Necrosis Factor (TNF) Decoy Receptors. J Biol Chem. 2015;290:15973-84 pubmed publisher |
Ersek A, Xu K, Antonopoulos A, Butters T, Santo A, Vattakuzhi Y, et al. Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. J Clin Invest. 2015;125:2279-92 pubmed publisher |
Li C, Cheng P, Liang M, Chen Y, Lu Q, Wang J, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015;125:1509-22 pubmed publisher |
Wang Y, Dong G, Jeon H, Elazizi M, La L, Hameedaldeen A, et al. FOXO1 mediates RANKL-induced osteoclast formation and activity. J Immunol. 2015;194:2878-87 pubmed publisher |
Guo T, Zhang L, Konermann A, Zhou H, Jin F, Liu W. Manganese superoxide dismutase is required to maintain osteoclast differentiation and function under static force. Sci Rep. 2015;5:8016 pubmed publisher |
Katsuyama E, Miyamoto H, Kobayashi T, Sato Y, Hao W, Kanagawa H, et al. Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells. J Biol Chem. 2015;290:716-26 pubmed publisher |
Rim Y, Yi H, Kim Y, Park N, Jung H, Kim J, et al. Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector. Sci Rep. 2014;4:6935 pubmed publisher |
Li S, Miller C, Giannopoulou E, Hu X, Ivashkiv L, Zhao B. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. J Clin Invest. 2014;124:5057-73 pubmed publisher |
Hassanpour S, Jiang H, Wang Y, Kuiper J, Glogauer M. The actin binding protein adseverin regulates osteoclastogenesis. PLoS ONE. 2014;9:e109078 pubmed publisher |
Salem S, Gao C, Li A, Wang H, Nguyen Yamamoto L, Goltzman D, et al. A novel role for interferon regulatory factor 1 (IRF1) in regulation of bone metabolism. J Cell Mol Med. 2014;18:1588-98 pubmed publisher |
Shimamura M, Nakagami H, Osako M, Kurinami H, Koriyama H, Zhengda P, et al. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. Proc Natl Acad Sci U S A. 2014;111:8191-6 pubmed publisher |
Yamasaki T, Ariyoshi W, Okinaga T, Adachi Y, Hosokawa R, Mochizuki S, et al. The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase. J Biol Chem. 2014;289:19191-203 pubmed publisher |
van de Pavert S, Ferreira M, Domingues R, Ribeiro H, Molenaar R, Moreira Santos L, et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature. 2014;508:123-7 pubmed publisher |
Pacheco Costa R, Hassan I, Reginato R, Davis H, Bruzzaniti A, Allen M, et al. High bone mass in mice lacking Cx37 because of defective osteoclast differentiation. J Biol Chem. 2014;289:8508-20 pubmed publisher |
He Q, Yang X, Gong Y, Kovalenko D, Canalis E, Rosen C, et al. Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity. J Bone Miner Res. 2014;29:1217-31 pubmed publisher |
Zhang Q, Liu M, Zhou Y, Liu W, Shen J, Shen Y, et al. The effect of alendronate on the expression of important cell factors in osteoclasts. Mol Med Rep. 2013;8:1195-203 pubmed publisher |
Zou W, Greenblatt M, Brady N, Lotinun S, Zhai B, de Rivera H, et al. The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2. J Exp Med. 2013;210:1793-806 pubmed publisher |
Fu J, Ling S, Liu Y, Yang J, Naveh S, Hannah M, et al. A small shared epitope-mimetic compound potently accelerates osteoclast-mediated bone damage in autoimmune arthritis. J Immunol. 2013;191:2096-103 pubmed publisher |
Bellon M, Ko N, Lee M, Yao Y, Waldmann T, Trepel J, et al. Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood. 2013;121:5045-54 pubmed publisher |
Kang H, Viollet B, Wu D. Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice. J Biol Chem. 2013;288:12187-96 pubmed publisher |
Yang J, Cho S, An J, Jung J, Kim S, Kim S, et al. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo. PLoS ONE. 2013;8:e56585 pubmed publisher |
Albers J, Keller J, Baranowsky A, Beil F, Catala Lehnen P, Schulze J, et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol. 2013;200:537-49 pubmed publisher |
Kim H, Prasad V, Hyung S, Lee Z, Lee S, Bhargava A, et al. Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival. J Cell Biol. 2012;199:1145-58 pubmed publisher |
Takito J, Nakamura M. Precursors linked via the zipper-like structure or the filopodium during the secondary fusion of osteoclasts. Commun Integr Biol. 2012;5:453-7 pubmed publisher |
Holoshitz J, Liu Y, Fu J, Joseph J, Ling S, Colletta A, et al. An HLA-DRB1-coded signal transduction ligand facilitates inflammatory arthritis: a new mechanism of autoimmunity. J Immunol. 2013;190:48-57 pubmed publisher |
Zhuang J, Zhang J, Lwin S, Edwards J, Edwards C, Mundy G, et al. Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS ONE. 2012;7:e48871 pubmed publisher |
He Y, Rhodes S, Chen S, Wu X, Yuan J, Yang X, et al. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions. PLoS ONE. 2012;7:e46900 pubmed publisher |
Lee J, Park H, Noh A, Kang J, Chen L, Zheng T, et al. 5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1. J Immunol. 2012;189:5284-92 pubmed publisher |
Blangy A, Touaitahuata H, Cres G, Pawlak G. Cofilin activation during podosome belt formation in osteoclasts. PLoS ONE. 2012;7:e45909 pubmed publisher |
Arriero M, Ramis J, Perell xf3 J, Monjo M. Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts. PLoS ONE. 2012;7:e43187 pubmed publisher |
Pulvino M, Liang Y, Oleksyn D, DeRan M, Van Pelt E, Shapiro J, et al. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood. 2012;120:1668-77 pubmed publisher |
Miyauchi Y, Miyamoto H, Yoshida S, Mori T, Kanagawa H, Katsuyama E, et al. Conditional inactivation of Blimp1 in adult mice promotes increased bone mass. J Biol Chem. 2012;287:28508-17 pubmed publisher |
Zhao E, Wang L, Dai J, Kryczek I, Wei S, Vatan L, et al. Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology. 2012;1:152-161 pubmed |
Kwok S, Park M, Cho M, Oh H, Park E, Lee D, et al. Retinoic acid attenuates rheumatoid inflammation in mice. J Immunol. 2012;189:1062-71 pubmed publisher |
Sanchez Fernandez M, Sbacchi S, Correa Tapia M, Naumann R, Klemm J, Chambon P, et al. Transgenic mice for a tamoxifen-induced, conditional expression of the Cre recombinase in osteoclasts. PLoS ONE. 2012;7:e37592 pubmed publisher |
Mieczkowska A, Basle M, Chappard D, Mabilleau G. Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism. J Biol Chem. 2012;287:23517-26 pubmed publisher |
Oikawa T, Oyama M, Kozuka Hata H, Uehara S, Udagawa N, Saya H, et al. Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. J Cell Biol. 2012;197:553-68 pubmed publisher |
Alwood J, Kumar A, Tran L, Wang A, Limoli C, Globus R. Low-dose, ionizing radiation and age-related changes in skeletal microarchitecture. J Aging Res. 2012;2012:481983 pubmed publisher |
Tarragona M, Pavlović M, Arnal Estapé A, Urosevic J, Morales M, Guiu M, et al. Identification of NOG as a specific breast cancer bone metastasis-supporting gene. J Biol Chem. 2012;287:21346-55 pubmed publisher |
Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H. Osteoprotection by semaphorin 3A. Nature. 2012;485:69-74 pubmed publisher |
Toro E, Zuo J, Ostrov D, Catalfamo D, Bradaschia Correa V, Arana Chavez V, et al. Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis. J Biol Chem. 2012;287:17894-904 pubmed publisher |
Swanson C, Akama Garren E, Stein E, Petralia J, Ruiz P, Edalati A, et al. Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis. J Immunol. 2012;188:3513-21 pubmed publisher |
Chabbi Achengli Y, Coudert A, Callebert J, Geoffroy V, Cote F, Collet C, et al. Decreased osteoclastogenesis in serotonin-deficient mice. Proc Natl Acad Sci U S A. 2012;109:2567-72 pubmed publisher |
Tsuji Takechi K, Negishi Koga T, Sumiya E, Kukita A, Kato S, Maeda T, et al. Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development. Proc Natl Acad Sci U S A. 2012;109:2561-6 pubmed publisher |
Nickerson N, Mohammad K, Gilmore J, Crismore E, Bruzzaniti A, Guise T, et al. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. PLoS ONE. 2012;7:e30255 pubmed publisher |
Zhao B, Grimes S, Li S, Hu X, Ivashkiv L. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med. 2012;209:319-34 pubmed publisher |
Little R, Muimo R, Robson L, Harris K, Grabowski P. The transient receptor potential ion channel TRPV6 is expressed at low levels in osteoblasts and has little role in osteoblast calcium uptake. PLoS ONE. 2011;6:e28166 pubmed publisher |
Stephens A, Stephens S, Morrison N. Internal control genes for quantitative RT-PCR expression analysis in mouse osteoblasts, osteoclasts and macrophages. BMC Res Notes. 2011;4:410 pubmed publisher |
He Y, Staser K, Rhodes S, Liu Y, Wu X, Park S, et al. Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS ONE. 2011;6:e24780 pubmed publisher |
Kertész Z, Gyori D, Körmendi S, Fekete T, Kis Toth K, Jakus Z, et al. Phospholipase C?2 is required for basal but not oestrogen deficiency-induced bone resorption. Eur J Clin Invest. 2012;42:49-60 pubmed publisher |
Zimmer S, Zhou Q, Zhou T, Cheng Z, Abboud Werner S, Horn D, et al. Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis. Blood. 2011;118:69-79 pubmed publisher |
Chen Z, Buki K, Vääräniemi J, Gu G, Vaananen H. The critical role of IL-34 in osteoclastogenesis. PLoS ONE. 2011;6:e18689 pubmed publisher |
Singbrant S, Russell M, Jovic T, Liddicoat B, Izon D, Purton L, et al. Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood. 2011;117:5631-42 pubmed publisher |
Liu S, Madiai F, Hackshaw K, Allen C, Carl J, Huschart E, et al. The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis. PLoS ONE. 2011;6:e17161 pubmed publisher |
Schmidt S, Nakchbandi I, Ruppert R, Kawelke N, Hess M, Pfaller K, et al. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J Cell Biol. 2011;192:883-97 pubmed publisher |
Newa M, Bhandari K, Tang L, Kalvapalle R, Suresh M, Doschak M. Antibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug. Pharm Res. 2011;28:1131-43 pubmed publisher |
Ishii M, Kikuta J, Shimazu Y, Meier Schellersheim M, Germain R. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med. 2010;207:2793-8 pubmed publisher |
Leung R, Cuddy K, Wang Y, Rommens J, Glogauer M. Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis. Blood. 2011;117:2044-53 pubmed publisher |
Pirih F, Michalski M, Cho S, Koh A, Berry J, Ghaname E, et al. Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS ONE. 2010;5:e13657 pubmed publisher |
Yazid M, Ariffin S, Senafi S, Razak M, Wahab R. Determination of the differentiation capacities of murines' primary mononucleated cells and MC3T3-E1 cells. Cancer Cell Int. 2010;10:42 pubmed publisher |
Nishikawa K, Nakashima T, Takeda S, Isogai M, Hamada M, Kimura A, et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J Clin Invest. 2010;120:3455-65 pubmed publisher |
Fuller K, Ross J, Szewczyk K, Moss R, Chambers T. Bone is not essential for osteoclast activation. PLoS ONE. 2010;5: pubmed publisher |
Sethi N, Yan Y, Quek D, Schupbach T, Kang Y. Rabconnectin-3 is a functional regulator of mammalian Notch signaling. J Biol Chem. 2010;285:34757-64 pubmed publisher |
Kang H, Chang W, Hurley M, VIGNERY A, Wu D. Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis. Proc Natl Acad Sci U S A. 2010;107:12901-6 pubmed publisher |
Hoshino A, Iimura T, Ueha S, Hanada S, Maruoka Y, Mayahara M, et al. Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts. J Biol Chem. 2010;285:28826-37 pubmed publisher |
Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R, Hoshi H, et al. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J Exp Med. 2010;207:751-62 pubmed publisher |
Ha J, Choi H, Lee Y, Kwon H, Song Y, Kim H. CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis. J Immunol. 2010;184:4717-24 pubmed publisher |
Chun J, Choi B, Lee K, Lee D, Kang D, Lee J, et al. Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation. PLoS ONE. 2010;5:e9422 pubmed publisher |
Paniagua R, Chang A, Mariano M, Stein E, Wang Q, Lindstrom T, et al. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis. Arthritis Res Ther. 2010;12:R32 pubmed publisher |
Hikiji H, Ishii S, Yokomizo T, Takato T, Shimizu T. A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss. Proc Natl Acad Sci U S A. 2009;106:21294-9 pubmed publisher |
Chan A, Jensen K, Skokos D, Doty S, Lederman H, Kaplan R, et al. Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS ONE. 2009;4:e7955 pubmed publisher |
Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, et al. Central control of fever and female body temperature by RANKL/RANK. Nature. 2009;462:505-9 pubmed publisher |
Whyte L, Ryberg E, Sims N, Ridge S, Mackie K, Greasley P, et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A. 2009;106:16511-6 pubmed publisher |
Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem. 2009;284:29087-96 pubmed publisher |
Reeve J, Zou W, Liu Y, Maltzman J, Ross F, Teitelbaum S. SLP-76 couples Syk to the osteoclast cytoskeleton. J Immunol. 2009;183:1804-12 pubmed publisher |
Kiesel J, Buchwald Z, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182:5477-87 pubmed publisher |
Inui M, Kikuchi Y, Aoki N, Endo S, Maeda T, Sugahara Tobinai A, et al. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc Natl Acad Sci U S A. 2009;106:4816-21 pubmed publisher |
Mizoguchi T, Muto A, Udagawa N, Arai A, Yamashita T, Hosoya A, et al. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol. 2009;184:541-54 pubmed publisher |
Ishii M, Egen J, Klauschen F, Meier Schellersheim M, Saeki Y, Vacher J, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009;458:524-8 pubmed publisher |
Hikata T, Takaishi H, Takito J, Hakozaki A, Furukawa M, Uchikawa S, et al. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood. 2009;113:2202-12 pubmed publisher |
Aliprantis A, Ueki Y, Sulyanto R, Park A, Sigrist K, Sharma S, et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest. 2008;118:3775-89 pubmed publisher |
Yano A, Tsutsumi S, Soga S, Lee M, Trepel J, Osada H, et al. Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proc Natl Acad Sci U S A. 2008;105:15541-6 pubmed publisher |
Zhu J, Jia X, Xiao G, Kang Y, Partridge N, Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem. 2007;282:26656-64 pubmed |
Yang S, Li Y. RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro. J Bone Miner Res. 2007;22:45-54 pubmed |
Park H, Jung Y, Park O, Lee Y, Choi J, Choi Y. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol. 2005;175:7193-201 pubmed |
